Sadhana Nitro Chem Board Proposes Key Financial Moves Ahead of Shareholder Vote

Sadhana Nitro Chem Limited announced on April 29, 2026, that its Board of Directors has proposed increasing the company's authorized share capital by ₹5.00 crore, to ₹305.00 crore. The Board also approved a preferential allotment of shares designed to raise approximately ₹13.90 crore.

Key Decisions from Board Meeting

The Board of Directors of Sadhana Nitro Chem Limited met on April 29, 2026, to review and approve several important corporate actions. Key decisions included proposing an increase to the company's authorized share capital from ₹300.00 crore to ₹305.00 crore. This change requires shareholder approval. The Board also approved a preferential allotment of 6,75,00,000 equity shares at ₹2.06 per share, aiming to raise approximately ₹13.90 crore. These funds are earmarked to strengthen the company's working capital, essential for supporting ongoing business operations. Additionally, the board regularized the appointment of Mrs. Sindhu Suneer Kotian as a Non-Executive Independent Director and approved the continuation of Mr. Asit Dhankumar Javeri as an Executive Director. An Extra-ordinary General Meeting (EGM) is scheduled for May 22, 2026, to seek shareholder consent for these proposed actions.

Significance of the Fundraise

The proposed capital infusion is important for Sadhana Nitro Chem to boost its liquidity and improve operational efficiency. Enhanced working capital is vital for smooth daily operations and managing short-term financial needs. This initiative demonstrates a proactive stance in financial management, aimed at supporting the company's future growth and stability.

About Sadhana Nitro Chem

Sadhana Nitro Chem Ltd primarily manufactures nitrocellulose and related chemical products. Companies in the chemical sector commonly use mechanisms like preferential allotments to secure funds for operational needs and expansion, a typical practice for managing corporate finances and ensuring business continuity.

Next Steps for Shareholders and Company

Shareholders will review and vote on the proposed capital increase and share allotment during the upcoming EGM. Following shareholder approval, the company plans to proceed with the share issuance to inject funds for working capital. The appointments of directors will be formally ratified by the members. The company's capital structure will be adjusted based on the shareholder decisions.

Key Risks and Conditions

Both the proposed increase in authorized share capital and the preferential allotment are contingent on receiving shareholder approval at the EGM. The successful completion of the preferential allotment also depends on obtaining all necessary regulatory and statutory clearances.

Industry Context: Peer Financing Practices

Prominent players in the Indian chemical industry, such as Aarti Industries Ltd and ATUL Ltd, frequently engage in capital raises to fund growth and manage operations. These companies often utilize various financial instruments, including equity issuances, to maintain financial flexibility and support strategic objectives.

Moving Forward: Key Watchpoints

• The outcome of the shareholder vote at the EGM on May 22, 2026.
• Confirmation of necessary regulatory approvals for the preferential allotment.
• Management's strategy for deploying the newly raised working capital.
• Further announcements regarding the completion of the share issuance and its financial impact.